---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-039020"
form_type: "8-K"
ticker: "XAIR"
cik: "0001641631"
company_name: "Beyond Air, Inc."
filed_at: "2026-08-18T20:30:32+00:00"
generated_at: "2026-08-18T20:32:25.268544+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Beyond Air Q1 revenue $1.8M flat YoY, net loss $7.9M; raises $30.1M financing, reaffirms CY2026 guidance

## Summary
- Revenue $1.8M flat YoY; gross margin improved to 13% from 9%.
- Net loss $7.9M ($11.00/share) vs $7.7M ($30.67/share) prior year.
- Cash $15.2M at June 30; subsequent up to $30.1M financing ($10.2M upfront, $20M warrants, $10M tied to FDA approval).
- Reaffirms CY2026 revenue guidance $8M; CY2027 $16-18M (110%+ growth).
- PMA supplement for 2nd-gen LungFit PH under FDA review; approval expected 2H CY2026; GPO deal adds ~2,000 hospitals.

## SEC filing metadata
- accession: 0001493152-26-039020
- form_type: 8-K
- ticker: XAIR
- cik: 0001641631
- company_name: Beyond Air, Inc.
- filed_at: 2026-08-18T20:30:32+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641631/000149315226039020/0001493152-26-039020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641631/000149315226039020/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-039020
- JSON: https://secwatch.observer/filing/0001493152-26-039020.json
- Plain text: https://secwatch.observer/filing/0001493152-26-039020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.